Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Pearson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical, Cosmetic and Investigational Dermatology|January 20, 2022
Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the ClinicianJessica J Padniewski, Rob L Shaver, Brittney Schultz, et al.
Journal of the American Board of Family Medicine : JABFM|April 5, 2022
Diagnosis and Management of Plantar DermatosesCody J Rasner, Sara A Kullberg, David R Pearson, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 12, 2022
3D Printed Skin-Interfaced UV-Visible Hybrid PhotodetectorsXia Ouyang, Ruitao Su, Daniel Wai Hou Ng, et al.
Blood Cells, Molecules & Diseases|December 5, 2021
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosisRoy L Kao, Audrey A Jacobsen, Charles J Billington, et al.
Journal of Strength and Conditioning Research|December 30, 2006
Determination of functional strength imbalance of the lower extremitiesRobert U Newton, Aimee Gerber, Sophia Nimphius, et al.
Journal of Strength and Conditioning Research|February 17, 2016
The Impact of Competitive Trait Anxiety on Collegiate Powerlifting PerformanceLawrence W Judge, Leslie J Urbina, Donald L Hoover, et al.
Frontiers in Immunology|November 30, 2019
Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in PemphigusRebecca L Krain, Carolyn J Kushner, Meera Tarazi, et al.
The Lancet. Rheumatology|May 10, 2026
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trialEric F Morand, Victoria P Werth, Joerg Wenzel, et al.
Lancet (London, England)|May 10, 2026
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trialEric F Morand, Maria Dall'Era, Jorge Sanchez-Guerrero, et al.
The American Journal of Clinical Nutrition|January 5, 2002
Elevated plasma 4-pyridoxic acid in renal insufficiencyStephen P Coburn, Robert D Reynolds, J Dennis Mahuren, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical, Cosmetic and Investigational Dermatology|January 20, 2022
Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the ClinicianJessica J Padniewski, Rob L Shaver, Brittney Schultz, et al.
Journal of the American Board of Family Medicine : JABFM|April 5, 2022
Diagnosis and Management of Plantar DermatosesCody J Rasner, Sara A Kullberg, David R Pearson, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 12, 2022
3D Printed Skin-Interfaced UV-Visible Hybrid PhotodetectorsXia Ouyang, Ruitao Su, Daniel Wai Hou Ng, et al.
Blood Cells, Molecules & Diseases|December 5, 2021
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosisRoy L Kao, Audrey A Jacobsen, Charles J Billington, et al.
Journal of Strength and Conditioning Research|December 30, 2006
Determination of functional strength imbalance of the lower extremitiesRobert U Newton, Aimee Gerber, Sophia Nimphius, et al.
Journal of Strength and Conditioning Research|February 17, 2016
The Impact of Competitive Trait Anxiety on Collegiate Powerlifting PerformanceLawrence W Judge, Leslie J Urbina, Donald L Hoover, et al.
Frontiers in Immunology|November 30, 2019
Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in PemphigusRebecca L Krain, Carolyn J Kushner, Meera Tarazi, et al.
The Lancet. Rheumatology|May 10, 2026
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trialEric F Morand, Victoria P Werth, Joerg Wenzel, et al.
Lancet (London, England)|May 10, 2026
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trialEric F Morand, Maria Dall'Era, Jorge Sanchez-Guerrero, et al.
The American Journal of Clinical Nutrition|January 5, 2002
Elevated plasma 4-pyridoxic acid in renal insufficiencyStephen P Coburn, Robert D Reynolds, J Dennis Mahuren, et al.
Pageof 2